Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
Financial Statements
- Click here to download Edwards Lifesciences Corp's Income Statement
- Click here to download Edwards Lifesciences Corp's Balance Sheet
- Click here to download Edwards Lifesciences Corp's Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Michael Mussallem
Key Statistics
- Stock Price: $117.72
- Dividend Yield: 0%
- Market Capitalization: $72,749,965,026
- Shares Outstanding: 621,316,637
- Number of Employees: 14,900
- Trailing 12-Month EPS: $2.38
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2022-04-19
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $117.72
- 52-week high: $131.73
- 52-week low: $83.12
- 200-day moving average: $114.81
- 50-day moving average: $109.52
Performance
- 1-Month Price Return: 3.6%
- 3-Month Price Return: -10.4%
- 6-Month Price Return: 3.1%
- 1-Year Price Return: 41.3%
- 2-Year Price Return: 79.2%
- 5-Year Price Return: 274.2%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast